vs

Side-by-side financial comparison of PATRICK INDUSTRIES INC (PATK) and Insulet Corporation (PODD). Click either name above to swap in a different company.

PATRICK INDUSTRIES INC is the larger business by last-quarter revenue ($924.2M vs $783.7M, roughly 1.2× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 3.1%, a 9.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 9.2%). PATRICK INDUSTRIES INC produced more free cash flow last quarter ($112.7M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs -0.5%).

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.

PATK vs PODD — Head-to-Head

Bigger by revenue
PATK
PATK
1.2× larger
PATK
$924.2M
$783.7M
PODD
Growing faster (revenue YoY)
PODD
PODD
+21.9% gap
PODD
31.2%
9.2%
PATK
Higher net margin
PODD
PODD
9.8% more per $
PODD
13.0%
3.1%
PATK
More free cash flow
PATK
PATK
$64.5M more FCF
PATK
$112.7M
$48.2M
PODD
Faster 2-yr revenue CAGR
PODD
PODD
Annualised
PODD
33.2%
-0.5%
PATK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PATK
PATK
PODD
PODD
Revenue
$924.2M
$783.7M
Net Profit
$29.1M
$101.6M
Gross Margin
23.0%
72.6%
Operating Margin
6.2%
18.7%
Net Margin
3.1%
13.0%
Revenue YoY
9.2%
31.2%
Net Profit YoY
99.7%
0.9%
EPS (diluted)
$0.82
$1.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PATK
PATK
PODD
PODD
Q4 25
$924.2M
$783.7M
Q3 25
$975.6M
$706.3M
Q2 25
$1.0B
$649.1M
Q1 25
$1.0B
$569.0M
Q4 24
$846.1M
$597.5M
Q3 24
$919.4M
$543.9M
Q2 24
$1.0B
$488.5M
Q1 24
$933.5M
$441.7M
Net Profit
PATK
PATK
PODD
PODD
Q4 25
$29.1M
$101.6M
Q3 25
$35.3M
$87.6M
Q2 25
$32.4M
$22.5M
Q1 25
$38.2M
$35.4M
Q4 24
$14.6M
$100.7M
Q3 24
$40.9M
$77.5M
Q2 24
$47.9M
$188.6M
Q1 24
$35.1M
$51.5M
Gross Margin
PATK
PATK
PODD
PODD
Q4 25
23.0%
72.6%
Q3 25
22.6%
72.2%
Q2 25
23.9%
69.7%
Q1 25
22.8%
71.9%
Q4 24
22.1%
72.1%
Q3 24
23.1%
69.3%
Q2 24
22.8%
67.7%
Q1 24
21.9%
69.5%
Operating Margin
PATK
PATK
PODD
PODD
Q4 25
6.2%
18.7%
Q3 25
6.8%
16.7%
Q2 25
8.3%
18.7%
Q1 25
6.5%
15.6%
Q4 24
4.7%
18.3%
Q3 24
8.1%
16.2%
Q2 24
8.3%
11.2%
Q1 24
6.4%
12.9%
Net Margin
PATK
PATK
PODD
PODD
Q4 25
3.1%
13.0%
Q3 25
3.6%
12.4%
Q2 25
3.1%
3.5%
Q1 25
3.8%
6.2%
Q4 24
1.7%
16.9%
Q3 24
4.4%
14.2%
Q2 24
4.7%
38.6%
Q1 24
3.8%
11.7%
EPS (diluted)
PATK
PATK
PODD
PODD
Q4 25
$0.82
$1.42
Q3 25
$1.01
$1.24
Q2 25
$0.96
$0.32
Q1 25
$1.11
$0.50
Q4 24
$-1.44
$1.38
Q3 24
$1.80
$1.08
Q2 24
$2.16
$2.59
Q1 24
$1.59
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PATK
PATK
PODD
PODD
Cash + ST InvestmentsLiquidity on hand
$26.4M
Total DebtLower is stronger
$1.3B
$930.8M
Stockholders' EquityBook value
$1.2B
$1.5B
Total Assets
$3.1B
$3.2B
Debt / EquityLower = less leverage
1.10×
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PATK
PATK
PODD
PODD
Q4 25
$26.4M
Q3 25
$20.7M
Q2 25
$22.0M
Q1 25
$86.6M
Q4 24
$33.6M
Q3 24
$52.6M
Q2 24
$44.0M
Q1 24
$17.6M
Total Debt
PATK
PATK
PODD
PODD
Q4 25
$1.3B
$930.8M
Q3 25
$934.9M
Q2 25
$939.0M
Q1 25
$1.6B
Q4 24
$1.3B
$1.3B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
PATK
PATK
PODD
PODD
Q4 25
$1.2B
$1.5B
Q3 25
$1.2B
$1.4B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$1.3B
Q4 24
$1.1B
$1.2B
Q3 24
$1.1B
$1.1B
Q2 24
$1.1B
$998.4M
Q1 24
$1.1B
$790.7M
Total Assets
PATK
PATK
PODD
PODD
Q4 25
$3.1B
$3.2B
Q3 25
$3.1B
$3.0B
Q2 25
$3.1B
$3.5B
Q1 25
$3.2B
$3.5B
Q4 24
$3.0B
$3.1B
Q3 24
$3.1B
$3.0B
Q2 24
$3.0B
$2.9B
Q1 24
$3.0B
$2.6B
Debt / Equity
PATK
PATK
PODD
PODD
Q4 25
1.10×
0.61×
Q3 25
0.68×
Q2 25
0.64×
Q1 25
1.21×
Q4 24
1.18×
1.07×
Q3 24
1.21×
Q2 24
1.36×
Q1 24
1.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PATK
PATK
PODD
PODD
Operating Cash FlowLast quarter
$130.8M
$183.3M
Free Cash FlowOCF − Capex
$112.7M
$48.2M
FCF MarginFCF / Revenue
12.2%
6.2%
Capex IntensityCapex / Revenue
2.0%
17.2%
Cash ConversionOCF / Net Profit
4.50×
1.80×
TTM Free Cash FlowTrailing 4 quarters
$246.5M
$377.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PATK
PATK
PODD
PODD
Q4 25
$130.8M
$183.3M
Q3 25
$9.1M
$125.7M
Q2 25
$149.4M
$196.5M
Q1 25
$40.1M
$63.8M
Q4 24
$102.7M
$147.7M
Q3 24
$51.5M
$98.5M
Q2 24
$137.5M
$96.5M
Q1 24
$35.2M
$87.6M
Free Cash Flow
PATK
PATK
PODD
PODD
Q4 25
$112.7M
$48.2M
Q3 25
$-17.2M
$100.1M
Q2 25
$131.1M
$177.9M
Q1 25
$19.9M
$51.5M
Q4 24
$77.2M
$94.1M
Q3 24
$33.7M
$71.8M
Q2 24
$120.6M
$74.0M
Q1 24
$19.7M
$65.5M
FCF Margin
PATK
PATK
PODD
PODD
Q4 25
12.2%
6.2%
Q3 25
-1.8%
14.2%
Q2 25
12.5%
27.4%
Q1 25
2.0%
9.1%
Q4 24
9.1%
15.7%
Q3 24
3.7%
13.2%
Q2 24
11.9%
15.1%
Q1 24
2.1%
14.8%
Capex Intensity
PATK
PATK
PODD
PODD
Q4 25
2.0%
17.2%
Q3 25
2.7%
3.6%
Q2 25
1.7%
2.9%
Q1 25
2.0%
2.2%
Q4 24
3.0%
9.0%
Q3 24
1.9%
4.9%
Q2 24
1.7%
4.6%
Q1 24
1.7%
5.0%
Cash Conversion
PATK
PATK
PODD
PODD
Q4 25
4.50×
1.80×
Q3 25
0.26×
1.43×
Q2 25
4.61×
8.73×
Q1 25
1.05×
1.80×
Q4 24
7.05×
1.47×
Q3 24
1.26×
1.27×
Q2 24
2.87×
0.51×
Q1 24
1.00×
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

PODD
PODD

U.S.Omnipod$567.8M72%
International Omnipod$214.0M27%
Drug Delivery$1.9M0%

Related Comparisons